
pmid: 16956591
We evaluated the effect of ebselen on human SH-SY5Y dopaminergic neuronal cells and determined whether ebselen, a glutathione peroxidase-mimetic, protected against MPTP-induced dopamine depletion in mice. Ebselen (10-100 microM) inhibited the proliferation of SH-SY5Y cells dose-dependently. Ebselen did not induce any behavioral changes and did not block MPTP-induced tremor and akinesia. Ebselen had no effect on the monoamine oxidase activity and did not protect against MPTP-induced dopamine depletion in striatum.
Azoles, Neurons, Glutathione Peroxidase, Dose-Response Relationship, Drug, Dopamine, Brain, Isoindoles, Antioxidants, Mice, Inbred C57BL, Disease Models, Animal, Mice, Oxidative Stress, Neuroprotective Agents, 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine, Cell Line, Tumor, Organoselenium Compounds, Animals, Humans, Monoamine Oxidase, Cell Proliferation
Azoles, Neurons, Glutathione Peroxidase, Dose-Response Relationship, Drug, Dopamine, Brain, Isoindoles, Antioxidants, Mice, Inbred C57BL, Disease Models, Animal, Mice, Oxidative Stress, Neuroprotective Agents, 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine, Cell Line, Tumor, Organoselenium Compounds, Animals, Humans, Monoamine Oxidase, Cell Proliferation
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 18 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
